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Introduction
Peripheral veno-arterial extracorporeal membrane oxygen-
ation (VA-ECMO) is increasingly used in acute, severe car-
diogenic shock refractory to conventional therapy. Although 
percutaneous femoral insertion of VA-ECMO is straightfor-
ward, the procedure is usually performed after intubation 
under general anaesthesia, and invasive ventilation is con-
tinued for the whole period of extracorporeal support.
Here, we show that VA-ECMO can be successfully per-
formed with neither (non-) invasive ventilation nor deep 
analgosedation.
A 51-year-old man with a history of hypertension and 
diabetes mellitus presented to the local hospital in cardio-
genic shock (blood pressure, 80/40 mmHg). Electrocardi-
ography (ECG) revealed a (sub)acute anterior myocardial 
infarction complicated by complete atrioventricular block 
and a slow ventricular escape rhythm of 30 beats per minute 
(Fig. 1). After initial medical therapy (volume resuscitation, 
inotropes), the clinical condition allowed urgent transport 
to an interventional centre. On arrival, immediate transve-
nous ventricular pacing was commenced, but did not lead 
to haemodynamic stabilisation. Echocardiography showed 
preserved wall thickness, but extensive apical and antero-
septal akinesia and inferior hypokinesia, with a large left 
ventricular (LV) apical thrombus (left ventricular ejection 
fraction (LVEF), 10 %).
Since cardiogenic shock persisted, VA-ECMO was initi-
ated under local anaesthesia via femoral access (25F venous 
cannula, 19F arterial cannula) as a bridge to recovery and 
additional therapy. During the procedure, the patient was 
fully awake, non-intubated and breathing oxygen through 
a non-rebreathing facemask. VA-ECMO yielded 4-L/
min flow, and a mean arterial pressure of 60–70 mmHg 
was achieved. An adequately supported circulation was 
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reflected by normal blood gas analysis, lactate levels, 
venous oxygen saturation and renal function; sinus rhythm 
ensued on day 2.
Coronary angiography revealed severe three-vessel dis-
ease (proximally occluded right, significantly stenosed cir-
cumflex and subtotally occluded left anterior descending 
coronary artery) unattractive for immediate revascularisa-
tion. The clinical course was complicated by obvious signs 
of pulmonary oedema on serial chest radiographs (Fig. 2) in 
the absence of dyspnoea (respiratory rate of 15–20 per min-
ute) and with adequate oxygenation (SaO2, 97–100 %; PaO2 
> 100 mmHg). Therefore, heart failure therapy (captopril, 
eplerenone, isosorbide mononitrate) was tailored with a pul-
monary artery catheter (PAC) and intensified (furosemide, 
hydrochlorothiazide) to accomplish negative fluid balances.
After 4 days of VA-ECMO under low-dose continued 
intravenous analgesia (1 mg morphine/h), support flow was 
gradually reduced (1 L/min per day) under therapeutic hepa-
rinisation and PAC monitoring. On day 8, echocardiography 
revealed partial LV recovery (LVEF, 25 %) during normally 
conducted sinus rhythm (Fig. 1) and 1 L/min support flow, 
allowing weaning off the VA-ECMO.
In a stable condition, the patient was mobilised and dis-
charged from the intensive care unit (ICU) on day 11. Based 
on myocardial viability studies (mid anteroseptal viability 
on cardiac magnetic resonance perfusion imaging), a drug-
eluting stent was placed in the left anterior descending 
artery on day 21, followed by clinical discharge on day 37.
Discussion
There is accumulating evidence that severe, refractory 
cardiogenic shock can be supported by percutaneous VA-
ECMO as a bridge to recovery, long-term mechanical sup-
port and eventually heart transplantation [1].
Yet, VA-ECMO is cumbersome, as patients are gener-
ally managed and instrumented in the ICU with invasive 
ventilation, analgosedation and feeding via a nasogastric 
tube. This renders VA-ECMO a complex and invasive 
therapeutic approach with numerous potential ICU-related 
complications.
In contrast to VA-ECMO standard care, we managed this 
case without intubation, ventilation or significant analgose-
dation, which has, to the best of our knowledge, not been 
reported in this way before [2]. We used PAC monitoring 
for haemodynamic tailoring and strived for optimal filling 
pressures (wedge pressures < 15 mmHg), while allowing 
adequate systemic VA-ECMO flow. During VA-ECMO 
weaning, we monitored cardiac recovery by continuously 
measuring intrinsic cardiac output on gradual daily reduc-
tion of support flow (Fig. 1). Moreover, spontaneous res-
piration was carefully monitored by pulse oximetry and 
repeated blood gas analyses, while pulmonary oedema was 
aggressively treated by combined diuretic therapy (Fig. 1). 
This strategy seems imperative as, for example, pneumo-
nia may render VA-ECMO without intubation impossible 
[2]. Others have reported on awake VA-ECMO requiring 
additional percutaneous atrioseptostomy to treat pulmo-
nary congestion, which was not necessary in our patient 
[3]. Moreover, neurological performance remained unre-
markable and could easily be evaluated in this cooperative 
patient. Neurological assessment is of utmost importance 
during peripheral VA-ECMO, especially on recovering car-
diac function and pending pulmonary oedema, which might 
cause hypoxaemia of the proximal aortic arch, that is, the 
Harlequin syndrome.
After roughly a week of VA-ECMO support, cardiac 
recovery was accompanied by immediate physical mobili-
sation creating optimal conditions for the subsequent clini-
cal course.
Fig. 2 Serial chest X-rays indicating decrease of pulmonary conges-
tion (upper panel). Daily cumulative fluid balance (middle panel). 
Daily gradual tapering of ECMO flow (L/min) during weaning off 
ECMO support (lower panel)
 
Fig. 1 Serial electrocardiograms (upper panel) and transthoracic 
echocardiograms (lower panel) on presentation (left) and on recovery 
6 weeks later (right) showing a large dilated anterior myocardial in-
farction with partial recovery of contractile function. Arrow indicates 
LV apical thrombus, which dissolved over time after therapeutic anti-
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Conclusion
VA-ECMO for severe and refractory cardiogenic shock may 
successfully be performed without mechanical ventilation. 
Careful monitoring of volume status and respiratory condi-
tion is imperative and allows keeping patients comfortable 
and cooperative also during prolonged periods of extracor-
poreal support. The limited invasiveness of this stand-alone 
VA-ECMO approach may encourage a more widespread 
and accessible use in cardiogenic shock.
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